Cleared by FDA and available for both total and unicompartmental knee arthroplasty, the handheld Cori robotics platform is meant to be faster than S+N’s previous Navio system. On top of Cori, the British medtech giant is also launching its Real Intelligence suite of digital surgery solutions that are meant to improve patient engagement, pre-operative planning, digital and robotic surgery, post-operative assessment and outcomes measurement.
“The Real Intelligence brand is a statement of how Smith+Nephew thinks, innovates,and reimagines surgery,” said Skip Kiil, president of Orthopaedics for Smith+Nephew.
“The introduction of the Cori surgical system’s handheld robotics, patient engagement tools, and outcomes measurement are the very first steps in a long-term strategy to advance orthopedics using technology,” Kiil said in a news release.
Smith+Nephew’s Cori system launch is the latest salvo as major medical device companies seek to take on Stryker (NYSE:SYK), which has enjoyed success with its Mako robotic systems in the orthopedic surgery space.
Smith+Nephew describes the new Cori system as small and portable, making it a good fit for ambulatory surgery centers (ASCs) and outpatient surgery. Compared with the Navio system, Cori’s new camera technology is more than four times faster, and its cutting technology can handle twice the cutting volume. Its modular design means that S+N could scale Cori to handle other types of orthopedic surgeries. Company officials say they will continue to introduce new applications.
“The Cori surgical system is truly next-generation robotics. Its efficient handheld form factor is ideal for surgery centers, which is where the market is moving, and it just erases away bone with the new bone milling technique,” said Dr. Jimmy Chow, an orthopedic surgeon at the Orthopedic Institute of the West. “The smart, intuitive software helps place and size the implant as well as balance gaps based on patient-specific anatomy and disease state.”
